Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_assertion type Assertion NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_head.
- NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_assertion description "[Within the placebo group, more CCA-IMT progression was found for smokers with the GSTM1-0 than for smokers with the GSTM1-1 genotype after adjustment for baseline IMT and major CVD risk factors (0.050 versus -0.002 mm, P=0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_provenance.
- NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_assertion evidence source_evidence_literature NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_provenance.
- NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_assertion SIO_000772 11500195 NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_provenance.
- NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_assertion wasDerivedFrom befree-20150227 NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_provenance.
- NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_assertion wasGeneratedBy ECO_0000203 NP437431.RAmtaOaPRGh-GYRRvR3Ohyt-YTSSQDk_H_KKafyhbte_Y130_provenance.